LONDON--(BUSINESS WIRE)--The global biopharmaceutical analytical testing services market 2018-2022 is expected to post a CAGR of close to 9% during the forecast period, according to the latest market research report by Technavio.
A key factor driving the growth of the market is the increase in demand for mAbs. These antibodies are proteins developed in the pharmaceutical and biotechnology laboratories to bind to the corresponding epitope of the antigen in the body. Therefore, several mAbs are used as healing agents to treat diseases like cancers. These antibodies are used as independent treatments or in conjugation with radiotherapy, drugs, or toxins to kill the infected cells.
This market research report on the global biopharmaceutical analytical testing services market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the rise in the production of vaccines as one of the key emerging trends in the global biopharmaceutical analytical testing services market:
Global biopharmaceutical analytical testing services market: Rise in the production of vaccines
Vaccines are beneficial to prevent infectious diseases such as diphtheria, Hepatitis B, and measles. It is one of the cost-effective and successful strategies to prevent health ailments. Around 15% to 20% of infants are unimmunized, which results in unnecessary death every year, particularly in the developing countries of Africa and South America. The major reason for this unimmunized population is low awareness and limitations on the production of vaccines.
“Vaccination is the effective way of preventing the spread of seasonal influenza whose effect is highly unpredictable. National Immunization program, organized by the WHO, aims at preventing disease, death, and disability by providing vaccination against diseases. Vaccines used in universal programs are effective in targeting, controlling, and eliminating illness,” says a senior analyst at Technavio for research on life science research tools.
Global biopharmaceutical analytical testing services market: Segmentation analysis
This market research report segments the global biopharmaceutical analytical testing services market by end-user (pharmaceutical and biotechnology companies, and contract research organizations (CROs)) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a share of more than 39%, followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the increased production of biologics and biosimilars.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market sizing
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
